Write For Us

WHO pauses trial of hydroxychloroquine in Covid-19 patients

E-Commerce Solutions SEO Solutions Marketing Solutions
86 Views
Published
The World Health Organization has suspended testing the malaria drug hydroxychloroquine in COVID-19 patients due to safety concerns, according to WHO Director General Tedros Adhanom.

Hydroxycholoroquine has been touted by Donald Trump and others as a possible treatment for the disease caused by the novel coronavirus. The US President has said he was taking the drug to help prevent infection.
Category
TV Saluran - TV Channel
Sign in or sign up to post comments.
Be the first to comment